Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 5 October

Jessica Amir
October 5, 2020

Weekly Wrap 2 October

Jessica Amir
October 2, 2020

Morning Bell 2 October

Jessica Amir
October 2, 2020

Morning Bell 1 October

Jessica Amir
October 1, 2020

Morning Bell 30 September

Jessica Amir
September 30, 2020

Morning Bell 29 September

Jessica Amir
September 29, 2020

Morning Bell 28 September

Jessica Amir
September 28, 2020

Weekly Wrap 25 September

Jessica Amir
September 25, 2020

Morning Bell 25 September

Jessica Amir
September 25, 2020

Morning Bell 24 September

Jessica Amir
September 24, 2020